Form 4 holding
EVP, Chief Scientific Officer
Intellia Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 77,388
- Estimated value
- $942,586
- Report date
- 03 Jan 2025
- Price
- $12.18
- Ownership
- Direct
Laura Sepp-Lorenzino - EVP, Chief Scientific Officer at Intellia Therapeutics, Inc.
Issuer-level insider activity
- Role
- EVP, Chief Scientific Officer
- Issuer ticker
- NTLA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Laura Sepp-Lorenzino since 13 Aug 2025
Reported holdings for Laura Sepp-Lorenzino in Intellia Therapeutics, Inc.
Form 4 holding
EVP, Chief Scientific Officer
Intellia Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 54,794
- Estimated value
- Report date
- 01 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Chief Scientific Officer
Intellia Therapeutics, Inc.
- Security class
- Restricted Stock Unit
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Laura Sepp-Lorenzino in Intellia Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.